Jonas Bovijn

Jonas Bovijn is a senior director and physician-scientist at Regeneron. Here are some key details about his background and experience:

Education and Qualifications

• MBChB (Bachelor of Medicine, Bachelor of Surgery)
• MRCP (UK) (Member of the Royal College of Physicians)
• MSc
• DPhil (Doctor of Philosophy)

Career at Regeneron

• Current Role: Senior Director (since January 2023)
• Previous Role: Associate Director (February 2021 - December 2022)

As an Associate Director, he worked as a physician scientist in cardiovascular, metabolic and skeletal disease translational genetics at the Regeneron Genetics Center (RGC).1

Previous Experience

• Technical Consultant at Bill & Melinda Gates Foundation (February 2019 - September 2020)
• Senior House Officer at NHS (January 2017 - May 2020)
• Honorary Registrar in Clinical Genetics at Oxford University Hospitals NHS Foundation Trust (July 2019 - January 2020)
• Medical Officer at Kimberley Hospital Complex, South Africa (January 2016 - September 2016)
• Medical Intern at Tygerberg Academic Hospital, South Africa (January 2014 - December 2015)1

Research Focus

At Regeneron, Jonas Bovijn focuses on using bioinformatics and epidemiological techniques to explore the use of human genetics in drug development, particularly for drug target identification and validation. He has expertise in:

• Designing, managing, and interpreting large-scale genetic and epidemiological analyses
• Implementing various analytic methods including genome-wide/phenome-wide association analyses, transcriptomic and proteomic data analysis, Mendelian randomization, and colocalization1

Awards and Honors

• New England Journal of Medicine Scholar (2012)
• Faculty of Medicine and Health Sciences Medal (2013)
• Chancellor's Medal from University of Stellenbosch (2013)
• Rhodes Scholarship (2015)1

Jonas Bovijn's diverse background in medicine, research, and industry positions him as a valuable asset in Regeneron's efforts to leverage genetic insights for drug development.